Sugiyama Kenji, Nozaki Takao, Asakawa Tetsuya, Sameshima Tetsuro, Koizumi Schinichiro, Hiramatsu Hisaya, Namba Hiroki
Department of Neurosurgery, Hamamatsu University School of Medicine.
Neurol Med Chir (Tokyo). 2018 Sep 15;58(9):369-376. doi: 10.2176/nmc.st.2018-0115. Epub 2018 Aug 9.
Deep brain stimulation (DBS) is used to treat symptoms by modulating the cortico-striato-thalamo-cortical (CSTC) loop in the central nervous system (CNS), and attempts to research loop circuit disorders have been globally initiated among the intractable neurological and psychiatric disorders. DBS treatment has been evaluated for all these newly found CNS loop circuit disorders. In 2011, neurosurgical treatments for psychiatric disorders were renamed from "psychosurgery" to "neurosurgery for psychiatric disorders (NPD)" by the World Society for Stereotactic and Functional Neurosurgery (WSSFN). Moreover, in 2014, "Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders" was published by the WSSFN to address the differences in correspondence of stereotactic NPD. Globally, two multicenter prospective randomized control trials regarding DBS of the subcallosal cingulated gyrus and ventral anterior internal capsule/ventral striatum for intractable depression have been terminated after futility analysis. However, DBS for intractable obsessive-compulsive disorder (OCD), unlike for intractable depression, is showing steady development. In Japan, NPDs have not been performed since 1975 following the adoption of "Resolution of total denial for psychosurgery" by the Japanese Society of Psychiatry and Neurology. Nevertheless, a trend to adopt new neuro-modulation techniques for psychiatric disorders, including DBS, are emerging. We have created a clinical research protocol for the use of DBS in intractable OCD, which has been approved by the ethical committee of Hamamatsu University School of Medicine, with the hope of commencing DBS treatment for intractable OCD patients in the near future.
深部脑刺激(DBS)通过调节中枢神经系统(CNS)中的皮质-纹状体-丘脑-皮质(CSTC)环路来治疗症状,并且针对难治性神经和精神疾病,全球范围内已启动了对该环路障碍的研究。已对所有这些新发现的中枢神经系统环路障碍进行了DBS治疗评估。2011年,世界立体定向和功能神经外科学会(WSSFN)将精神疾病的神经外科治疗从“精神外科”更名为“精神疾病神经外科(NPD)”。此外,2014年,WSSFN发布了“精神疾病立体定向神经外科治疗指南共识”,以解决立体定向NPD对应方面的差异。在全球范围内,两项关于扣带回下束和腹侧前内囊/腹侧纹状体DBS治疗难治性抑郁症的多中心前瞻性随机对照试验在无效性分析后已终止。然而,与难治性抑郁症不同,DBS治疗难治性强迫症(OCD)正在稳步发展。在日本,自1975年日本精神神经学会通过“全面拒绝精神外科手术的决议”以来,未进行过NPD手术。尽管如此,包括DBS在内的用于精神疾病的新神经调节技术的采用趋势正在出现。我们已经制定了一项在难治性OCD中使用DBS的临床研究方案,该方案已获得浜松医科大学伦理委员会的批准,希望在不久的将来开始为难治性OCD患者进行DBS治疗。